James Shin
Stock Analyst at Deutsche Bank
(2.77)
# 1,916
Out of 5,182 analysts
25
Total ratings
58.33%
Success rate
23.14%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Shin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STRO Sutro Biopharma | Maintains: Buy | $51 → $55 | $33.59 | +63.74% | 2 | Mar 25, 2026 | |
| LLY Eli Lilly and Company | Maintains: Buy | $1,200 → $1,285 | $868.27 | +48.00% | 6 | Feb 9, 2026 | |
| MRK Merck & Co. | Maintains: Hold | $110 → $111 | $110.23 | +0.70% | 3 | Nov 18, 2025 | |
| IMTX Immatics | Initiates: Buy | $10 | $11.35 | -11.89% | 1 | May 28, 2025 | |
| GILD Gilead Sciences | Upgrades: Buy | $80 → $120 | $127.75 | -6.07% | 2 | Feb 18, 2025 | |
| AMGN Amgen | Reiterates: Hold | $310 → $305 | $340.18 | -10.34% | 2 | Aug 7, 2024 | |
| INCY Incyte | Maintains: Hold | $55 → $60 | $95.72 | -37.31% | 2 | Aug 1, 2024 | |
| BMY Bristol-Myers Squibb Company | Maintains: Hold | $53 → $45 | $57.78 | -22.12% | 3 | Jul 23, 2024 | |
| LEGN Legend Biotech | Initiates: Buy | $60 | $23.65 | +153.70% | 1 | May 23, 2024 | |
| ABBV AbbVie | Initiates: Hold | $150 | $197.38 | -24.00% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $800 | $744.44 | +7.46% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.42 | +604.23% | 1 | Nov 9, 2023 |
Sutro Biopharma
Mar 25, 2026
Maintains: Buy
Price Target: $51 → $55
Current: $33.59
Upside: +63.74%
Eli Lilly and Company
Feb 9, 2026
Maintains: Buy
Price Target: $1,200 → $1,285
Current: $868.27
Upside: +48.00%
Merck & Co.
Nov 18, 2025
Maintains: Hold
Price Target: $110 → $111
Current: $110.23
Upside: +0.70%
Immatics
May 28, 2025
Initiates: Buy
Price Target: $10
Current: $11.35
Upside: -11.89%
Gilead Sciences
Feb 18, 2025
Upgrades: Buy
Price Target: $80 → $120
Current: $127.75
Upside: -6.07%
Amgen
Aug 7, 2024
Reiterates: Hold
Price Target: $310 → $305
Current: $340.18
Upside: -10.34%
Incyte
Aug 1, 2024
Maintains: Hold
Price Target: $55 → $60
Current: $95.72
Upside: -37.31%
Bristol-Myers Squibb Company
Jul 23, 2024
Maintains: Hold
Price Target: $53 → $45
Current: $57.78
Upside: -22.12%
Legend Biotech
May 23, 2024
Initiates: Buy
Price Target: $60
Current: $23.65
Upside: +153.70%
AbbVie
Nov 9, 2023
Initiates: Hold
Price Target: $150
Current: $197.38
Upside: -24.00%
Nov 9, 2023
Initiates: Hold
Price Target: $800
Current: $744.44
Upside: +7.46%
Nov 9, 2023
Initiates: Buy
Price Target: $10
Current: $1.42
Upside: +604.23%